Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression

Cytotherapy

Volumn 14, Issue 1, 2012, Pages 70-79

  Yang, Heung Mo ^a   Sung, Ji Hye ^b   Choi, Young Sil ^b   Lee, Hyun Joo ^b   Roh, Cheong Rae ^a   Kim, Jongman ^a   Shin, Milljae ^a   Song, Sanghyun ^a   Kwon, Choon Hyuck ^a   Joh, Jae Won ^a   Kim, Sung Joo ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

human leukocyte antigen G; immunosuppressive effect; lentiviral system; mesenchymal stromal cells

Indexed keywords

HLA G ANTIGEN; HLA G1 ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG;

ADIPOSE TISSUE CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; FETUS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYME CELL; MESENCHYME STROMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE EXPRESSION; STROMA CELL;

EID: 83755188620     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.613926     Document Type: Article

References (45)

1. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-4. (Pubitemid 27161245)
2. Dexter TM, Spooncer E, Schofi eld R, Lord BI, Simmons P. Hematopoietic stem cells and the problem of self-renewal. Blood Cells. 1984;10:315-39. (Pubitemid 16239823)
3. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000; 164:247-56. (Pubitemid 32008970)
4. Weng YS, Lin HY, Hsiang YJ, Hsieh CT, Li WT. The effects of different growth factors on human bone marrow stromal cells differentiating into hepatocyte-like cells. Adv Exp Med Biol. 2003;534:119-28.
5. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93-8. (Pubitemid 34049148)
6. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues: Cloning in vitro and retransplantation in vivo. Transplantation. 1974; 17:331-40.
7. Keating A, Singer JW, Killen PD, Striker GE, Salo AC, Sanders J, et al. Donor origin of the in vitro hematopoietic microenvironment after marrow transplantation in man. Nature. 1982;298:280-3. (Pubitemid 12089415)
8. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-95. (Pubitemid 35471185)
9. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells. 2005; 23:220-9. (Pubitemid 40239517)
10. Shih DT, Lee DC, Chen SC, Tsai RY, Huang CT, Tsai CC, et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells. 2005;23: 1012-20. (Pubitemid 41170957)
11. In ' t Anker PS, Scherjon SA, Kleijburg-van Der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338-45. (Pubitemid 39636409)
12. In ' t Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88:845-52. (Pubitemid 37128084)
13. Aggarwal S, Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105:1815-22. (Pubitemid 40223708)
14. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al. Treatment of severe acute graftversus- host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-41. (Pubitemid 38586721)
15. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecifi c mitogenic stimuli. Blood. 2002;99:3838-43. (Pubitemid 34534559)
16. Meisel R, Zibert A, Laryea M, Göbel U, D ä ubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103:4619-21. (Pubitemid 38745993)
17. Nasef A, Mathieu N, Chapel A, Frick J, Fran ç ois S, Mazurier C, et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007;84: 231-7. (Pubitemid 47205757)
18. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Classimolecule. J Immunol. 1990;144:731-5. (Pubitemid 20036109)
19. Mallet V, Blaschitz A, Crisa L, Schmitt C, Fournel S, King A, et al. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83(- ) dendritic cells expresses LA-G as a membrane-bound and soluble protein. Int Immunol. 1999;11:889-98.
20. Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, et al. The classiHLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes. 2006;55:1214-22. (Pubitemid 44195357)
21. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism? Cancer Res. 2005;65:10139-44. (Pubitemid 41743699)
22. Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain. 2005;128: 2689-704. (Pubitemid 41552952)
23. Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N. HLA-G molecules: From maternal - fetal tolerance to tissue acceptance. Adv Immunol. 2003;81:199-252. (Pubitemid 38009044)
24. Colonna M, Navarro F, Bellon T, Llano M, Garc í a P, Samaridis J, et al. A common inhibitory receptor for major histocompatibility complex classimolecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186: 1809-18. (Pubitemid 27524591)
25. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O ' Callaghan CA, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC classimolecules. J Immunol. 1998;160:3096-100. (Pubitemid 28164696)
26. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specifi c receptor expressed on all natural killer cells. J Exp Med. 1999;189:1093-100.
27. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA. 1997;94:11520-5. (Pubitemid 27451031)
28. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecifi c CTL cytolysis. J Immunol. 2001;166:5018-26.
29. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(- ) T-lymphocytes. J Reprod Immunol. 2000;48:17-26.
30. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol. 2005;35:1133-42. (Pubitemid 40542220)
31. Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, et al. HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical classigenes transcription and protein expression. Human Immunol. 2000;61: 1177-95. (Pubitemid 32043896)
32. Campagnoli C, Roberts Irene AG, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identifi cation of mesenchymal stem/ progenitor cells in human fi rst-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396-402.
33. Hoogduijn MJ, Crop MJ, Peeters AMA, Van Osch GJ, Balk AH, Ijzermans JN, et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007;16:597-604. (Pubitemid 47378732)
34. Cherry, Yasumizu R, Toki J, Asou H, Nishino T, Komatsu Y, et al. Production of hematopoietic stem cell- chemotactic factor by bone marrow stromal cells. Blood. 1994;83:964-71. (Pubitemid 24058546)
35. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5:485-9. (Pubitemid 38028708)
36. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specifi c T cells to their cognate peptide. Blood. 2003;101:3722-9. (Pubitemid 36857965)
37. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al. Immunomodulatory effect of human adipose tissuederived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129:118-29. (Pubitemid 40524060)
38. Boyson JE, Iwanaga KK, Golos TG, Watkins DI. Identifi cation of a novel MHC classigene, Mamu-AG, expressed in the placenta of a primate with an inactivated G locus. J Immunol. 1997;159:3311-21. (Pubitemid 127482089)
39. Boyson JE, Iwanaga KK, Urvater JA, Hughes AL, Golos TG, Watkins DI. Evolution of a new nonclassical MHC classilocus in two Old World primate species. Immunogenetics. 1999;49:86-98. (Pubitemid 29037596)
40. Comiskey M, Goldstein CY, De Fazio SR, Mammolenti M, Newmark JA, Warner CM. Evidence that HLA-G is the functional homolog of mouse Qa-2, the Ped gene product. Human Immunol. 2003;64:999-1004. (Pubitemid 37413706)
41. Stroynowski I, Tabaczewski P. Multiple products of class Ib Qa-2 genes: which ones are functional? Res Immunol. 1996; 147:290-301. (Pubitemid 26258841)
42. Cao W, Brenner CA, Alikani M, Cohen J, Warner CM. Search for a human homologue of the mouse Ped gene. Mol Hum Reprod. 1999;5:541-7. (Pubitemid 29251633)
43. Menier C, Riteau B, Carosella ED, Rouas-Freiss N. MICA triggering signal for NK cell tumor lysis is counteracted by HLAG1- mediated inhibitory signal. Int J Cancer. 2002;100:63-70. (Pubitemid 34602066)
44. Creput C, Durrbach A, Menier C, Guettier C, Samuel D, Dausset J, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver - kidney transplantation. J Hepatol. 2003;39:587-94. (Pubitemid 37204660)
45. van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod. 2007; 13:123-33. (Pubitemid 46152599)